Home/Filings/4/0001628280-23-039535
4//SEC Filing

Moran Susan 4

Accession 0001628280-23-039535

CIK 0001825367other

Filed

Nov 16, 7:00 PM ET

Accepted

Nov 17, 6:36 PM ET

Size

5.2 KB

Accession

0001628280-23-039535

Insider Transaction Report

Form 4
Period: 2023-11-17
Moran Susan
Chief Medical Officer
Transactions
  • Award

    Stock Option (right to buy)

    2023-11-17+164,000164,000 total
    Exercise: $22.72Exp: 2033-11-16Common Stock (164,000 underlying)
Footnotes (1)
  • [F1]The shares subject to the option vest in a series of 48 successive equal monthly installments over the four-year period measured from the date of grant.

Issuer

RayzeBio, Inc.

CIK 0001825367

Entity typeother

Related Parties

1
  • filerCIK 0001835225

Filing Metadata

Form type
4
Filed
Nov 16, 7:00 PM ET
Accepted
Nov 17, 6:36 PM ET
Size
5.2 KB